πŸ‡ΊπŸ‡Έ FDA
Patent

US 11834439

Compounds, compositions, and methods

granted A61PA61P1/04A61P19/02

Quick answer

US patent 11834439 (Compounds, compositions, and methods) held by DENALI THERAPEUTICS INC. expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DENALI THERAPEUTICS INC.
Grant date
Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P1/04, A61P19/02, A61P21/00, A61P25/00